Total Funding
11
22
Total FundingVenture - Series Unknown raised
Growth Score 11 in past quarter
-2 pts
Heat Score 22 in past quarter
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
528424
CBLPath is a provider of sub-specialized anatomic pathology and molecular diagnostic laboratory services.
- David McGinnis: Co-Founder & Senior Vice President of Billing and Managed Care
- Carlos Urmacher: Co-Founder, Chief Executive Officer and Chief Medical Officer
About the Company
CBLPath, Inc. is a leading provider of sub-specialized anatomic pathology and molecular diagnostic laboratory services. They are committed to partnering with their physician-clients to provide the best possible patient care. Founded in 1988 as Cytopath Biopsy Lab, their landmark laboratory quickly established a reputation for providing definitive
diagnoses coupled with extraordinary customer service.
